Filing Details

Accession Number:
0001968202-24-000119
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-08-15 16:01:19
Reporting Period:
2024-08-13
Accepted Time:
2024-08-15 16:01:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
872589 Regeneron Pharmaceuticals Inc. REGN Pharmaceutical Preparations (2834) 133444607
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1796226 J Andrew Murphy 777 Old Saw Mill River Road
Tarrytown NY 10591
Evp Research No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-08-13 20,000 $399.66 68,306 No 4 M Direct
Common Stock Disposition 2024-08-13 13,637 $1,141.49 54,669 No 4 F Direct
Common Stock Disposition 2024-08-14 55 $1,140.31 54,614 No 4 S Direct
Common Stock Disposition 2024-08-14 48 $1,142.94 54,566 No 4 S Direct
Common Stock Disposition 2024-08-14 79 $1,143.28 54,487 No 4 S Direct
Common Stock Disposition 2024-08-14 45 $1,144.89 54,442 No 4 S Direct
Common Stock Disposition 2024-08-14 148 $1,145.58 54,294 No 4 S Direct
Common Stock Disposition 2024-08-14 51 $1,146.60 54,243 No 4 S Direct
Common Stock Disposition 2024-08-14 537 $1,148.52 53,706 No 4 S Direct
Common Stock Disposition 2024-08-14 294 $1,149.60 53,412 No 4 S Direct
Common Stock Disposition 2024-08-14 844 $1,150.41 52,568 No 4 S Direct
Common Stock Disposition 2024-08-14 185 $1,151.46 52,383 No 4 S Direct
Common Stock Disposition 2024-08-14 197 $1,152.36 52,186 No 4 S Direct
Common Stock Disposition 2024-08-14 987 $1,153.74 51,199 No 4 S Direct
Common Stock Disposition 2024-08-14 777 $1,154.66 50,422 No 4 S Direct
Common Stock Disposition 2024-08-14 402 $1,155.76 50,020 No 4 S Direct
Common Stock Disposition 2024-08-14 1,016 $1,156.43 49,004 No 4 S Direct
Common Stock Disposition 2024-08-14 178 $1,157.41 48,826 No 4 S Direct
Common Stock Disposition 2024-08-14 189 $1,158.78 48,637 No 4 S Direct
Common Stock Disposition 2024-08-14 331 $1,159.69 48,306 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2024-08-13 20,000 $0.00 20,000 $399.66
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2024-12-16 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 4,326 Indirect By 401(k) Plan
Footnotes
  1. Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on May 9, 2023.
  2. Represents volume-weighted average price of sales of 148 shares of Company stock on August 14, 2024 at prices ranging from $1,145.33 to $1,145.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price.
  3. Represents volume-weighted average price of sales of 537 shares of Company stock on August 14, 2024 at prices ranging from $1,148.06 to $1,148.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price.
  4. Represents volume-weighted average price of sales of 294 shares of Company stock on August 14, 2024 at prices ranging from $1,149.13 to $1,149.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price.
  5. Represents volume-weighted average price of sales of 844 shares of Company stock on August 14, 2024 at prices ranging from $1,150.10 to $1,150.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price.
  6. Represents volume-weighted average price of sales of 185 shares of Company stock on August 14, 2024 at prices ranging from $1,151.09 to $1,151.49. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price.
  7. Represents volume-weighted average price of sales of 197 shares of Company stock on August 14, 2024 at prices ranging from $1,152.27 to $1,152.60. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price.
  8. Represents volume-weighted average price of sales of 987 shares of Company stock on August 14, 2024 at prices ranging from $1,153.07 to $1,153.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price.
  9. Represents volume-weighted average price of sales of 777 shares of Company stock on August 14, 2024 at prices ranging from $1,154.05 to $1,154.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price.
  10. Represents volume-weighted average price of sales of 402 shares of Company stock on August 14, 2024 at prices ranging from $1,155.04 to $1,155.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price.
  11. Represents volume-weighted average price of sales of 1,016 shares of Company stock on August 14, 2024 at prices ranging from $1,156.06 to $1,156.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price.
  12. Represents volume-weighted average price of sales of 178 shares of Company stock on August 14, 2024 at prices ranging from $1,157.13 to $1,157.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price.
  13. Represents volume-weighted average price of sales of 189 shares of Company stock on August 14, 2024 at prices ranging from $1,158.53 to $1,158.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price.
  14. Represents volume-weighted average price of sales of 331 shares of Company stock on August 14, 2024 at prices ranging from $1,159.21 to $1,159.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price.
  15. The stock option award vests in four equal annual installments, commencing one year after the date of grant.